Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

L1 GROUP LIMITED Share Issue/Capital Change 2016

Jun 27, 2016

65211_rns_2016-06-27_3dc0fca5-e8c2-41c4-aed6-5586db060785.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Platinum Asset Management Limited (the Company )

ABN

13 050 064 287

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or
to be issued (if known) or
maximum number which may
be issued
3
Principal
terms
of
the
+securities
(e.g.
if
options,
exercise price and expiry date; if
partly
paid
+securities,
the
amount outstanding and due
dates
for
payment;
if
+convertible
securities,
the
conversion price and dates for
conversion)
Deferred Rights (not quoted) to receive an
equivalent number of the Company’s shares.
Upon exercise of the Deferred Rights,
employees will receive shares in the Company
that have been previously acquired on-market
by the Company’s Employee Share Trust and
held on behalf of employees.
591,578 Deferred Rights allocated under the
Platinum Asset Management Limited Deferred
Bonus Plan (Plan)
See Annexure A
4
Do the+securities rank equally
in all respects from the+issue
date with an existing+class of
quoted+securities?
If the additional+securities do
not rank equally, please state:
• the date from which they do
• the extent to which they
participate
for
the
next
dividend, (in the case of a
trust,
distribution)
or
interest payment
• the extent to which they do
not rank equally, other than
in
relation
to
the
next
dividend,
distribution
or
interest payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for
the acquisition of assets, clearly
identify those assets)
6a
Is the entity an+eligible entity
that
has
obtained
security
holder approval under rule 7.1A?
If Yes, complete sections 6b – 6h
in relation to the+securities the
subject of this Appendix 3B, and
comply with section 6i
6b
The date the security holder
resolution under rule 7.1A was
passed
6c
Number of+securities issued
without security holder approval
under rule 7.1
6d
Number of+securities issued
with security holder approval
under rule 7.1A
No, the Deferred Rights do not rank equally in
all respects with the existing class of quoted
securities.
Prior to the Deferred Rights being exercised,
there is no entitlement to vote and receive
dividends.
After the Deferred Rights have vested and been
exercised, the employee will receive ordinary
shares (previously purchased on-market).
These ordinary shares will rank equally with the
existing class of quoted securities (including an
entitlement to vote and receive dividends).
Nil
Issue of Deferred Rights under the
Plan in respect of the 2016 financial year.
No
Not applicable
Not applicable
Not applicable
  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

6e
Number of+securities issued
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)
6f
Number of+securities issued
under an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on
which
valuation
of
consideration was released to
ASX Market Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
Not applicable
Not applicable

Not applicable
Not applicable
Not applicable

7 +Issue dates 24 June 2016 Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. Number +Class 8 Number and +class of all 586,678,900 Fully paid ordinary +securities quoted on ASX shares ( including the +securities in section 2 if applicable) Number +Class 9 Number and +class of all 591,578 Deferred Rights +securities not quoted on ASX allocated under the ( including the +securities in Plan. section 2 if applicable) We note that, on exercise of the Deferred Rights, any shares issued under the Plan will have been previously acquired on-market. Therefore, no new shares will be issued under the Plan.

10 Dividend policy (in the case of a Not applicable trust, distribution policy) on the increased capital (interests)

  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Part 2 - Pro rata issue

Items 11 to 33 are not applicable

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1

(b) All other[+] securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Items 34 to 42 are not applicable.

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

    • Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 28/06/2016 (Company secretary)

Print name: ................Janna Vynokur.........................................

== == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Appendix 3B – Annexure A

Item 3 – Principal terms of the securities

Nature of Deferred
Rights
Each Deferred Right represents a right to receive one
(1) ordinary share in the capital of the Company,
subject to the terms and conditions of the Plan rules.
Prior to a Deferred Right being exercised an eligible
employee is not entitled to any voting rights or to
receive dividends.
The Company’s shares that will be allocated to each
eligible employee will, prior to exercise, be acquired (by
a separate employee share trust) on-market and not
through the issue of new shares.
Unvested Deferred Rights will lapse on cessation of
employment exceptifthe board decides otherwise.
Determination of the
Number of Deferred
Rights
The number of Deferred Rights has been determined
by dividing an eligible employees’ Deferred Bonus
award by $6.17 being the volume weighted average
price (VWAP) of the Company’s shares based on the
end of day closing share price over the 7 trading days
prior to 20 June 2016 (Grant Date).
Grant Date 20 June 2016
Acceptance Date 24 June 2016
Vesting Date 20 June 2020
Exercise Expiry Date 20 June 2025
Vesting Conditions Continuous employment until the Vesting Date
Deferred Right Exercise
Price
Nil
Dividend Equivalent
Payment
The Deferred Rights also carry an entitlement to a
Dividend Equivalent Payment.
Upon the valid exercise of a Deferred Right, or deemed
exercise, of a Deferred Right, an eligible employee will
be entitled to receive an amount approximately equal to
the amount of dividends that would have been paid to
the eligible employee had they held the share from the
Grant Date to the date that the Deferred Rights are
exercised.
  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013